Study Summary
This trial will study how men and women differ in their reaction to marijuana.
Eligible Conditions
- Cannabis
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: 25 minutes after THC infusion begins
25 minutes after THC infusion begins
Verbal Learning: measured by Rey Auditory Verbal Learning Test (AVLT)
changes in "high" assessed over the following timepoints: baseline, +10, +80, and +200 minutes after THC infusion begins
Rewarding Effects measured by Visual Analog Scale (VAS)
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
THC
1 of 2
Placebo
1 of 2
Active Control
Non-Treatment Group
100 Total Participants · 2 Treatment Groups
Primary Treatment: THC · Has Placebo Group · Phase 1
Placebo
Drug
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: DrugTHC
Drug
ActiveComparator Group · 1 Intervention: THC · Intervention Types: DrugTrial Logistics
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 25 minutes after thc infusion begins
Who is running the clinical trial?
Yale UniversityLead Sponsor
1,679 Previous Clinical Trials
21,087,939 Total Patients Enrolled
13 Trials studying Cannabis
663 Patients Enrolled for Cannabis
Eligibility Criteria
Age 18 - 55 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments